Carregant...
VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer
BACKGROUND: Anti-angiogenesis therapy that targets VEGF is one of the important treatment strategies in advanced ovarian cancer. However, depending on the pharmaceutical agent, treatment can have undesirable side effects. SEMA4D has recently gained interest for its role in promoting angiogenesis. He...
Guardat en:
| Publicat a: | Cell Mol Biol Lett |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5751932/ https://ncbi.nlm.nih.gov/pubmed/29308068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s11658-017-0058-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|